Literature DB >> 9270410

Low insulin sensitivity is associated with clustering of cardiovascular disease risk factors.

L Mykkänen1, S M Haffner, T Rönnemaa, R N Bergman, M Laakso.   

Abstract

Hyperinsulinemia is associated with multiple metabolic disorders including high triglyceride level, low high density lipoprotein (HDL) cholesterol level, hypertension, and impaired glucose tolerance (IGT). This metabolic constellation is also called the insulin resistance syndrome. All previous data on clustering of these risk factors are, however, based on insulin levels. Therefore, the authors examined the association of insulin sensitivity estimated by means of a frequently sampled intravenous glucose tolerance test and the minimal model with the number of metabolic disorders (dyslipidemia [high triglyceride level or low HDL cholesterol level or both], hypertension, and IGT according to the World Health Organization criteria). Of 153 nondiabetic subjects aged 53-61 years who had participated in a previous population-based study, 79 had no disorders, 55 had one disorder, 16 had two disorders, and 3 had three disorders. Insulin sensitivity index (S1) decreased with the increasing number of disorders (4.1, 3.5, 1.8, and 1.4 x 10(-4) min-1 microU-1 mL-1, in subjects with 0, 1, 2, and 3 disorders, respectively; p < 0.001 for trend). Similarly, fasting (7.5, 7.8, 15.3, and 22.0 microU/mL; p < 0.001) and 2-hour insulin levels (39.9, 49.0, 98.7, and 149.6 microU/mL; p < 0.001) increased by the increasing number of disorders. The relations of S1 and fasting and 2-hour insulin levels with multiple metabolic disorders were independent of sex, obesity, and body fat distribution. Furthermore, these associations were similar in men and women and in lean and obese subjects. The authors conclude that a clustering of cardiovascular disease risk factors in nondiabetic subjects is not only associated with hyperinsulinemia but also with insulin resistance.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9270410     DOI: 10.1093/oxfordjournals.aje.a009272

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  11 in total

1.  Localization of atherosclerosis susceptibility loci to chromosomes 4 and 6 using the Ldlr knockout mouse model.

Authors:  C L Welch; S Bretschger; N Latib; M Bezouevski; Y Guo; N Pleskac; C P Liang; C Barlow; H Dansky; J L Breslow; A R Tall
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

2.  Differentials and Determinants of Syndrome 'X' and its Role as Coronary Risk among Healthy Middle Aged Indian Army Personnel.

Authors:  Rajvir Bhalwar; V C Ohri; B L Somani; A S Kasthuri
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.

Authors:  Robert Ratner; Ronald Goldberg; Steven Haffner; Santica Marcovina; Trevor Orchard; Sarah Fowler; Marinella Temprosa
Journal:  Diabetes Care       Date:  2005-04       Impact factor: 19.112

Review 4.  The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  R Kahn; J Buse; E Ferrannini; M Stern
Journal:  Diabetologia       Date:  2005-09       Impact factor: 10.122

5.  Basal insulin resistance and secretion in Nigerians with type 2 diabetes mellitus.

Authors:  J M Oli; A A Adeyemo; G O Okafor; E N Ofoegbu; B Onyenekwe; C J Chukwuka; C N Onwasigwe; S Ufelle; G Chen; C N Rotimi
Journal:  Metab Syndr Relat Disord       Date:  2009-12       Impact factor: 1.894

6.  Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies.

Authors: 
Journal:  Diabetologia       Date:  2004-07-07       Impact factor: 10.122

7.  Risk factors for type 2 diabetes mellitus preceded by β-cell dysfunction, insulin resistance, or both in older adults: the Cardiovascular Health Study.

Authors:  Fumiaki Imamura; Kenneth J Mukamal; James B Meigs; José A Luchsinger; Joachim H Ix; David S Siscovick; Dariush Mozaffarian
Journal:  Am J Epidemiol       Date:  2013-05-24       Impact factor: 4.897

8.  Baseline levels, and changes over time in body mass index and fasting insulin, and their relationship to change in metabolic trait clustering.

Authors:  Martin K Rutter; Lisa M Sullivan; Caroline S Fox; Peter W F Wilson; David M Nathan; Ramachandran S Vasan; Ralph B D'Agostino; James B Meigs
Journal:  Metab Syndr Relat Disord       Date:  2014-07-09       Impact factor: 1.894

9.  The correlation between thyrotropin and dyslipidemia in a population-based study.

Authors:  Li Lu; Beibei Wang; Zhongyan Shan; Fengwei Jiang; Xiaochun Teng; Yanyan Chen; Yaxin Lai; Jiani Wang; Haibo Xue; Sen Wang; Chenyan Li; He Liu; Ningna Li; Jiashu Yu; Liangfeng Shi; Xin Hou; Qian Xing; Xue Bai; Weiping Teng
Journal:  J Korean Med Sci       Date:  2011-01-24       Impact factor: 2.153

10.  Elevated fasting insulin predicts the future incidence of metabolic syndrome: a 5-year follow-up study.

Authors:  Ki-Chul C Sung; Mi-Hae H Seo; Eun-Jung J Rhee; Andrew M Wilson
Journal:  Cardiovasc Diabetol       Date:  2011-11-30       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.